U.S. Polymerase Chain Reaction Market Size & Outlook
U.S. polymerase chain reaction market, 2018-2030 (US$M)
Related Markets
U.S. polymerase chain reaction market highlights
- The U.S. polymerase chain reaction market generated a revenue of USD 10,243.0 million in 2023 and is expected to reach USD 5,310.6 million by 2030.
- The U.S. market is expected to grow at a CAGR of -9% from 2024 to 2030.
- In terms of segment, conventional pcr was the largest revenue generating type in 2023.
- Conventional PCR is the most lucrative type segment registering the fastest growth during the forecast period.
Polymerase chain reaction market data book summary
| Market revenue in 2023 | USD 10,243.0 million |
| Market revenue in 2030 | USD 5,310.6 million |
| Growth rate | -9% (CAGR from 2023 to 2030) |
| Largest segment | Conventional pcr |
| Fastest growing segment | Conventional PCR |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Conventional PCR |
| Key market players worldwide | Thermo Fisher Scientific Inc, Danaher Corp, Abbott Laboratories, Bio-Rad Laboratories Inc, Agilent Technologies Inc, Qiagen NV, Roche Holding AG ADR, Standard BioTools Inc, Stilla, Microsynth |
Other key industry trends
- In terms of revenue, U.S. accounted for 33.0% of the global polymerase chain reaction market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In North America, U.S. polymerase chain reaction market is projected to lead the regional market in terms of revenue in 2030.
- Canada is the fastest growing regional market in North America and is projected to reach USD 635.7 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Polymerase Chain Reaction Market Scope
Polymerase Chain Reaction Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
U.S. polymerase chain reaction market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to polymerase chain reaction market will help companies and investors design strategic landscapes.
Conventional pcr was the largest segment with a revenue share of 4.99% in 2023. Horizon Databook has segmented the U.S. polymerase chain reaction market based on conventional pcr covering the revenue growth of each sub-segment from 2018 to 2030.
Increasing prevalence of cancer & chronic diseases and the growing need for their treatment are expected to fuel the demand in the market. In addition, the growing prevalence of other chronic diseases, infectious diseases, and genetic disorders is increasing the demand for efficient diagnostic tests, thereby driving growth in the PCR market. Furthermore, the unprecedented COVID-19 outbreak in the country was another factor propelling the market growth.
To address the unmet needs in the pandemic, key players increased the manufacturing of testing kits. Favorable government initiatives and flexible regulatory guidelines are also anticipated to increase the demand for PCR tests. For instance, on February 4, 2020, the Department of Health and Human Services announced Emergency Use Authorizations (EUAs) for diagnostics to detect COVID-19.
Reasons to subscribe to U.S. polymerase chain reaction market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of U.S. polymerase chain reaction market databook
-
Our clientele includes a mix of polymerase chain reaction market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. polymerase chain reaction market , including forecasts for subscribers. This country databook contains high-level insights into U.S. polymerase chain reaction market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
U.S. polymerase chain reaction market size, by type, 2018-2030 (US$M)
U.S. Polymerase Chain Reaction Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
